Japan records surprise trade deficit in July as exports weaken further
Director Nicholas Sheridan Lewin reported purchasing 2,600 shares of Establishment Labs Holdings Inc. (NASDAQ:ESTA) on August 14, 2025, at a price of $37.85 per share. The total value of the purchase was $98,410. The stock, currently trading at $36.39, has seen analysts set price targets ranging from $40 to $70, with a strong buy consensus. With a market capitalization of $1.04 billion, InvestingPro analysis shows the company maintains healthy liquidity with a current ratio of 2.84x.
Following the transaction, Mr. Lewin directly owns 1,075,923 shares and indirectly owns 19,090 shares of the company through his spouse. Want deeper insights into insider trading patterns and comprehensive financial analysis? InvestingPro offers exclusive access to detailed insider trading analytics and over 30 key financial metrics for Establishment Labs Holdings.
In other recent news, Establishment Labs has been the focus of several analyst updates and evaluations. Mizuho raised its price target for the company to $70.00 from $58.00, maintaining an Outperform rating, citing the success of the Motiva breast implant product in the U.S. market following FDA approval. Meanwhile, Needham reiterated its Buy rating with a $48.00 price target after an investor day event, where plastic surgeons expressed optimism about the company’s market share growth in the U.S. over the next few years. BTIG also initiated coverage with a Buy rating and a $62.00 price target, highlighting the innovative design and safety profile of Motiva implants as a competitive edge in the medical aesthetics industry.
Additionally, Needham upgraded Establishment Labs from Hold to Buy, setting a price target at $48.00, due to reduced trade tensions and the potential of products like Mia and Preservé in international markets. Analysts at Needham also noted optimism about the upcoming U.S. launch of Motiva, anticipating a positive impact on the company’s performance by 2025. These developments underscore the growing confidence among analysts in Establishment Labs’ ability to expand its market presence and enhance its product offerings.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.